QUOTIENT LTD (QTNT) Stock Fundamental Analysis
NASDAQ:QTNT - Nasdaq - JE00BNNSZY03 - Common Stock - Currency: USD
We assign a fundamental rating of 1 out of 10 to QTNT. QTNT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. QTNT has a bad profitability rating. Also its financial health evaluation is rather negative. QTNT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
QTNT had negative earnings in the past year.
QTNT had a negative operating cash flow in the past year.
QTNT had negative earnings in each of the past 5 years.
QTNT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The profitability ratios for QTNT are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for QTNT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
QTNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QTNT has been increased compared to 1 year ago.
QTNT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -11.49, we must say that QTNT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.49, QTNT is doing worse than 84.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.49 |
ROIC/WACCN/A
WACC8.48%
2.3 Liquidity
A Current Ratio of 1.79 indicates that QTNT should not have too much problems paying its short term obligations.
QTNT has a worse Current ratio (1.79) than 79.00% of its industry peers.
QTNT has a Quick Ratio of 1.36. This is a normal value and indicates that QTNT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.36, QTNT is not doing good in the industry: 74.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
The earnings per share for QTNT have decreased strongly by -11.79% in the last year.
Looking at the last year, QTNT shows a small growth in Revenue. The Revenue has grown by 1.85% in the last year.
Measured over the past years, QTNT shows a quite strong growth in Revenue. The Revenue has been growing by 11.62% on average per year.
EPS 1Y (TTM)-11.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.09%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y9.76%
Revenue growth 5Y11.62%
Sales Q2Q%-6.45%
3.2 Future
The Earnings Per Share is expected to grow by 14.78% on average over the next years. This is quite good.
QTNT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.13% yearly.
EPS Next Y44.75%
EPS Next 2Y31.45%
EPS Next 3Y16.98%
EPS Next 5Y14.78%
Revenue Next Year6.8%
Revenue Next 2Y21.99%
Revenue Next 3Y19.62%
Revenue Next 5Y16.13%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QTNT. In the last year negative earnings were reported.
Also next year QTNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as QTNT's earnings are expected to grow with 16.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.45%
EPS Next 3Y16.98%
5. Dividend
5.1 Amount
QTNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.38
+0.01 (+2.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.2%
Inst Owner Change0%
Ins Owners71.36%
Ins Owner Change0%
Market Cap1.29M
Analysts85.71
Price Target61.2 (16005.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-212.08%
Min EPS beat(2)-229.77%
Max EPS beat(2)-194.39%
EPS beat(4)0
Avg EPS beat(4)-157.49%
Min EPS beat(4)-229.77%
Max EPS beat(4)-82.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.74%
Min Revenue beat(2)-21.78%
Max Revenue beat(2)-17.7%
Revenue beat(4)1
Avg Revenue beat(4)-11.06%
Min Revenue beat(4)-21.78%
Max Revenue beat(4)3.88%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-33.33%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3437.42%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-53.21
EYN/A
EPS(NY)-13.06
Fwd EYN/A
FCF(TTM)-37.36
FCFYN/A
OCF(TTM)-36.7
OCFYN/A
SpS11.08
BVpS-53.62
TBVpS-53.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 34.49% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | -11.49 |
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)41.7%
Cap/Depr(5y)74.02%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.09%
EPS Next Y44.75%
EPS Next 2Y31.45%
EPS Next 3Y16.98%
EPS Next 5Y14.78%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y9.76%
Revenue growth 5Y11.62%
Sales Q2Q%-6.45%
Revenue Next Year6.8%
Revenue Next 2Y21.99%
Revenue Next 3Y19.62%
Revenue Next 5Y16.13%
EBIT growth 1Y-27.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.41%
EBIT Next 3Y12.08%
EBIT Next 5Y4.76%
FCF growth 1Y-74.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.8%
OCF growth 3YN/A
OCF growth 5YN/A